ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Statin Use May Be Associated with Lower Risk of Invasive Aspergillosis in Lung Transplant Recipients

A. Perez Cortes Villalobos, F. Foroutan, S. Davoudi, T. Martinu, J. Tikkanen, L. Singer, S. Keshavjee, S. Husain

University Health Network, Toronto, ON, Canada

Meeting: 2020 American Transplant Congress

Abstract number: C-187

Keywords: Fungal infection, Infection, Lung, Lung transplantation

Session Information

Session Name: Poster Session C: All Infections (Excluding Kidney & Viral Hepatitis)

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Statins are competitive inhibitors of HMG-CoA reductase, that catalyses the conversion of HMG-CoA to mevalonate, which is involved in the synthesis of cholesterol in humans and ergosterol in fungi. However, the effect of statin use on the risk of invasive aspergillosis (IA) in lung transplant recipients (LTRs) is not well documented.

*Methods: Consecutive LTRs from January 2010 to December 2014 were evaluated with one year follow-up from transplant. Proven or probable IA was diagnosed as per ISHLT criteria. A multivariate analysis of known risk factors of IA and statin use (minimum of two week before IA) was performed.

*Results: We identified 520 LTRs, 55% male, the median age 52 years old, the most common underlying disease was pulmonary fibrosis 130(25%). 48 (9.2%) LTRs developed IA in the first-year post-transplant. 53%(274/520) of the LTRs received statin. Atorvastatin was the most common used statin (70.4%). Out of the 48 LTRs only 12.5%( 6) had received statin prior the development of IA. The multivariate analysis of risk factors is shown in table 1. Statin use (OR 0.09;95%CI 0.04-0.24), double lung transplant (OR 0.38;95%CI 0.17-0.84) significantly decreased the risk of subsequent development of IA .

*Conclusions: Use of statin for a minimum of two weeks during first year of transplant was independently associated with decreased risk of IA in LTRs.

Multivariate analysis of risk factors for IA in LTRs
OR 95% CI p
STATIN USE 0.09 0.04-0.24 0.00
ANTIFUNGAL PREEMPTIVE THERAPY 0.46 0.10-2.08 0.31
DOUBLE LUNG TRANSPLANT 0.38 0.17-0.84 0.01
PRETRANSPLANT ASPERGILLOSIS 2.61 1.00-6.79 0.04
  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Villalobos APerezCortes, Foroutan F, Davoudi S, Martinu T, Tikkanen J, Singer L, Keshavjee S, Husain S. Statin Use May Be Associated with Lower Risk of Invasive Aspergillosis in Lung Transplant Recipients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/statin-use-may-be-associated-with-lower-risk-of-invasive-aspergillosis-in-lung-transplant-recipients/. Accessed May 9, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences